The University of Chicago Header Logo

Connection

Helen S. Te to Drug Therapy, Combination

This is a "connection" page, showing publications Helen S. Te has written about Drug Therapy, Combination.
Connection Strength

0.171
  1. Peginterferon alpha-2a combination therapies in chronic hepatitis C patients who relapsed after or had a viral breakthrough on therapy with standard interferon alpha-2b plus ribavirin: a pilot study of efficacy and safety. Dig Dis Sci. 2005 Apr; 50(4):719-26.
    View in: PubMed
    Score: 0.054
  2. Autoimmune hepatitis: a histological variant associated with prominent centrilobular necrosis. Gut. 1997 Aug; 41(2):269-71.
    View in: PubMed
    Score: 0.031
  3. Sofosbuvir plus ledispasvir for recurrent hepatitis C in liver transplant recipients. Liver Transpl. 2016 11; 22(11):1536-1543.
    View in: PubMed
    Score: 0.030
  4. An interferon-free antiviral regimen for HCV after liver transplantation. N Engl J Med. 2014 Dec 18; 371(25):2375-82.
    View in: PubMed
    Score: 0.026
  5. Evaluation of early null response to pegylated interferon and ribavirin as a predictor of therapeutic nonresponse in patients undergoing treatment for chronic hepatitis C. Am J Gastroenterol. 2011 Mar; 106(3):452-8.
    View in: PubMed
    Score: 0.020
  6. Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome. Am J Gastroenterol. 2001 Oct; 96(10):2984-91.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.